Detalhe da pesquisa
1.
Enhanced safety surveillance of STAMARIL® yellow fever vaccine provided under the expanded access investigational new drug program in the USA.
J Travel Med
; 30(7)2023 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37000007
2.
Yellow fever vaccine usage in the United States and risk of neurotropic and viscerotropic disease: A retrospective cohort study using three healthcare databases.
Vaccine
; 40(5): 742-751, 2022 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34996642
3.
Immunogenicity and safety of booster CYD-TDV dengue vaccine after alternative primary vaccination schedules in healthy individuals aged 9-50 years: a randomised, controlled, phase 2, non-inferiority study.
Lancet Infect Dis
; 22(6): 901-911, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35364022
4.
Immunogenicity and safety of simplified vaccination schedules for the CYD-TDV dengue vaccine in healthy individuals aged 9-50 years (CYD65): a randomised, controlled, phase 2, non-inferiority study.
Lancet Infect Dis
; 21(4): 517-528, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33212067